Armes J E, Egan A J, Southey M C, Dite G S, McCredie M R, Giles G G, Hopper J L, Venter D J
Molecular Pathology Laboratory, Victorian Breast Cancer Research Consortium, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia.
Cancer. 1998 Dec 1;83(11):2335-45.
Women with breast carcinoma diagnosed before age 40 years have a greater prevalence of germline BRCA1 and BRCA2 mutations than women with breast carcinoma diagnosed at older ages. Several recognizable histologic characteristics have been identified in breast carcinoma from studies of BRCA1/2 mutation carriers who belong to multiple-case families. The authors attempted to determine whether breast carcinoma occurring before age 40 years in BRCA1 or BRCA2 mutation carriers who were not selected for family history could be distinguished histologically from one another and from breast carcinoma in women of a similar age without a germline BRCA1 or BRCA2 mutation.
The study undertook a histologic assessment of breast carcinomas diagnosed before age 40 years identified from a population-based study.
Breast carcinoma in BRCA1 mutation carriers was associated with a distinct histologic appearance; these tumors were high grade, and had exceptionally high mean mitotic counts, a syncytial growth pattern, pushing margins, and confluent necrosis. Atypical medullary carcinoma was overrepresented in BRCA1 mutation carriers. All low grade tumors and tumors with low mitotic rates belonged to the group without BRCA1 or BRCA2 mutations. Pleomorphic lobular carcinomas and extensive intraduct carcinomas were more common in BRCA2 mutation carriers.
Breast carcinoma occurring in women with a germline BRCA1 or BRCA2 mutation have recognizable histologic phenotypes, which may be useful in identifying individuals more likely to carry germline mutations. Histologic examination of breast carcinoma should become an important part of the evaluation of women seeking genetic testing for germline mutations in these breast carcinoma susceptibility genes.
40岁前被诊断为乳腺癌的女性,其生殖系BRCA1和BRCA2基因突变的患病率高于年龄较大时被诊断为乳腺癌的女性。在对属于多病例家族的BRCA1/2突变携带者的乳腺癌研究中,已确定了几种可识别的组织学特征。作者试图确定,在未根据家族病史进行选择的BRCA1或BRCA2突变携带者中,40岁前发生的乳腺癌在组织学上是否彼此有区别,以及与年龄相仿但无生殖系BRCA1或BRCA2突变的女性的乳腺癌是否有区别。
该研究对从一项基于人群的研究中确定的40岁前被诊断为乳腺癌的病例进行了组织学评估。
BRCA1突变携带者的乳腺癌具有独特的组织学表现;这些肿瘤分级高,平均有丝分裂计数异常高,呈合体生长模式,边缘呈推挤状,并有融合性坏死。非典型髓样癌在BRCA1突变携带者中占比过高。所有低级别肿瘤和有丝分裂率低的肿瘤都属于无BRCA1或BRCA2突变的组。多形性小叶癌和广泛的导管内癌在BRCA2突变携带者中更为常见。
生殖系BRCA1或BRCA2突变女性发生的乳腺癌具有可识别的组织学表型,这可能有助于识别更有可能携带生殖系突变的个体。乳腺癌的组织学检查应成为对这些乳腺癌易感基因进行生殖系突变基因检测的女性评估的重要组成部分。